Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism

作者: Davide Brancato , Alessandro Scorsone , Gabriella Saura , Lidia Ferrara , Anna Di Noto

DOI: 10.4158/EP13418.OR

关键词:

摘要: Objective: A great number of factors can interfere with levothyroxine (LT4) tablet absorption, leading to increased serum thyroid-stimulating hormone (TSH) levels and, accordingly, LT4 requirements. oral solution (LT4-OS) is a novel formulation pharmacokinetics profile different from those tablets. The aim this study was retrospectively evaluate whether TSH were decreased after switching adult hypothyroid patients the LT-OS.Methods: We evaluated 53 outpatients on replacement therapy (consumed within 1 hour before breakfast) who switched tablets LT4-OS without changing daily dose. compared preswitch (TSH1) level 60 90 days switch (TSH2) and examined clinical differences between whose did not drop switch.Results: After switch, median value 3.04 (interquartile range [IQR] 1.75-6.80) 2.30 (IQR 1.21-3.81) μIU/m...

参考文章(31)
M. Vaisman, L. S. Ward, H. Graf, F. Vaisman, G. Carvalho, R. Montenegro, C. Medina Coeli, How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study. Journal of Endocrinological Investigation. ,vol. 36, pp. 485- 488 ,(2013) , 10.3275/8810
Olympia Koulouri, Mohammed A. Auldin, Ravi Agarwal, Veronica Kieffer, Carole Robertson, James Falconer Smith, Miles J. Levy, Trevor A. Howlett, Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under‐replacement with levothyroxine Clinical Endocrinology. ,vol. 74, pp. 744- 749 ,(2011) , 10.1111/J.1365-2265.2011.03984.X
Alessandra Cassio, Sara Monti, Angela Rizzello, Ilaria Bettocchi, Federico Baronio, Graziana D'Addabbo, Milva Orquidea Bal, Antonio Balsamo, Comparison between Liquid and Tablet Formulations of Levothyroxine in the Initial Treatment of Congenital Hypothyroidism The Journal of Pediatrics. ,vol. 162, pp. 1264- 1269 ,(2013) , 10.1016/J.JPEDS.2012.11.070
Ingeborg Walter-Sack, Christof Clanget, Reinhard Ding, Christoph Goeggelmann, Vera Hinke, Matthias Lang, Johannes Pfeilschifter, Yorki Tayrouz, Karl Wegscheider, Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposures. Clinical Pharmacokinectics. ,vol. 43, pp. 1037- 1053 ,(2004) , 10.2165/00003088-200443140-00006
Salvatore Benvenga, Luigi Bartolone, Maria Angela Pappalardo, Antonia Russo, Daniela Lapa, Grazia Giorgianni, Giovanna Saraceno, Francesco Trimarchi, Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. ,vol. 18, pp. 293- 301 ,(2008) , 10.1089/THY.2007.0222
Serenella Checchi, Annalisa Montanaro, Letizia Pasqui, Cristina Ciuoli, Valentina De Palo, Maria Celeste Chiappetta, Furio Pacini, L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 465- 469 ,(2008) , 10.1210/JC.2007-1544
Dimple Pabla, Fatemeh Akhlaghi, Hossein Zia, A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 72, pp. 105- 110 ,(2009) , 10.1016/J.EJPB.2008.10.008
Issac Sachmechi, David Reich, Michael Aninyei, Francisca Wibowo, Garima Gupta, Paul Kim, Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocrine Practice. ,vol. 13, pp. 345- 349 ,(2007) , 10.4158/EP.13.4.345
Ryuji Iemura, Masanori Toyota, Mark J. Micallef, Effects of type of diet on pharmacokinetics of levothyroxine sodium oral solution. Research in Veterinary Science. ,vol. 94, pp. 695- 697 ,(2013) , 10.1016/J.RVSC.2012.12.010